Stock Comparison
JAZZ vs REGN
Jazz Pharmaceuticals PLC and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$14.45B
$66.35B
P/E (TTM)
1,916.8
15.5
Forward P/E
12.6
14.1
Price/Sales
3.3
4.5
Price/Book
3.2
2.1
EV/EBITDA
25.2
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
0.66%
29.60%
Operating Margin
23.50%
20.70%
Return on Equity
0.68%
14.50%
Return on Assets
6.92%
6.13%
Growth (YoY)
Revenue Growth
19.10%
19.00%
Earnings Growth
3.20%
-7.20%
Price & Risk
Beta
0.3
0.2
52-Week High
$243.32
$818.90
52-Week Low
$105.00
$516.07
Analyst Target
$257.00
$833.31
Compare JAZZ and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.